Detlef Schuppan International Celiac Disease Symposium 2026

Abstracts this author is presenting:

• Clinical, histologic and safety outcomes of ZED1227 treatment in symptomatic celiac disease patients: results from the phase 2b CEC-004/CEL randomized clinical trial — Lunch & Elevated Poster Presentation Session 1